Drug Updates Articles
Clear filter
Pharmacist's Application to Practice: Pirtobrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Cristina V. Martinez, PharmD, PGY2 Oncology Pharmacy Resident, and Hunter Sowell, PharmD, BCOP, Clinical Pharmacy Specialist Oncology, analyze the potential role for pirtobrutinib in treating chronic lymphocytic leukemia and small lymphocytic lymphoma.
Pharmacist's Application to Practice: Zongertinib
Reyam Katchi, PharmD, PGY2 Hematology/Oncology Pharmacy Resident, and Kiera Roubal, PharmD, Oncology Clinical Pharmacist, break down the potential role for zongertinib in the treatment of non-squamous NSCLC with HER2 TKD activating mutations.
Pharmacist's Application to Practice: Taletrectinib
Benjamin Pastore, PharmD, PGY2 Adult Oncology Pharmacy Resident, and Jasmine Patel, PharmD, BCOP, Clinical Pharmacy Specialist - Thoracic Oncology, discuss the potential role of taletrectinib in the treatment of metastatic non-small cell lung cancer.
Pharmacist's Application to Practice: Obecabtagene autoleucel
Crystal Chung, PharmD, PGY2 Oncology Pharmacy Resident, and Emma Sheldon, PharmD, BCOP, Oncology Pharmacy Specialist - Bone Marrow Transplant/Cellular Therapy, both from Scripps Health in San Diego, CA, discuss obecabtagene autoleucel (Aucatzyl).
Pharmacist's Application to Practice: Dordaviprone
Nghi Nguyen, PharmD, PGY1 Pharmacy Resident, and Andrea Clarke, PharmD, BCOP, Hematology/Cellular Therapy Clinical Pharmacy Specialist - both from Wellstar MCG Health in Augusta, GA - deep dive into the potential role and clinical pearls of dordaviprone.
Pharmacist's Application to Practice: Linvoseltamab-gcpt
Nikki Kalem, PharmD, PGY2 Oncology Pharmacy Resident, at Henry Ford Hospital in Detroit, MI, writes about the recent accelerated approval of linvoseltamab-gcpt for the treatment of relapsed or refractory multiple myeloma in adults.
Pharmacist's Application to Practice: Remestemcel-L-rknd
Erin Lexner, PharmD, BCPS, PGY-2 Oncology Pharmacy Resident, and Christine Barrett, PharmD, BCOP, Oncology Pharmacy Specialist - both from Mary Babb Randolph Cancer Center at West Virginia University Hospitals - write about remestemcel-L-rknd.
Pharmacist's Application to Practice: Mirdametinib
Ramsey Shane, PharmD, MPH, PGY1 Pharmacy Resident, and Rebecca Pokorny, PharmD, BCPS, BCOP, Clinical Pharmacist Specialist Neuro-Oncology - both from Vanderbilt University Medical Center, Nashville, TN - write about mirdametinib (Gomekli).
Pharmacist's Application to Practice: Ensartinib
Savannah Young, PharmD, PGY1 Pharmacy Resident, from Sarasota Memorial Hospital, Sarasota, FL, and Kiera Roubal, PharmD, BCOP, Clinical Oncology Pharmacist Specialist, from Medical University of South Carolina, Charleston, SC, write about ensartinib.
